Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
Yazar: | Tear, L |
---|---|
Diğer Yazarlar: | Faulkner, S |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2018
|
Konular: |
Benzer Materyaller
-
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
Yazar:: Zahra Sahraei, ve diğerleri
Baskı/Yayın Bilgisi: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
Yazar:: Marco Moscatelli, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01) -
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
Yazar:: Johannes M. Froehlich, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01) -
Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
Yazar:: Nacif Marcelo S, ve diğerleri
Baskı/Yayın Bilgisi: (2012-02-01) -
Toxicity associated with gadolinium-based contrast-enhanced examinations
Yazar:: Silvia Maria Lattanzio
Baskı/Yayın Bilgisi: (2021-05-01)